February 13, 2020 / 2:01 PM / 4 days ago

BRIEF-Avenue Therapeutics Announces New Drug Application For IV Tramadol Accepted For Review By FDA

Feb 13 (Reuters) - Avenue Therapeutics Inc:

* AVENUE THERAPEUTICS ANNOUNCES NEW DRUG APPLICATION FOR IV TRAMADOL ACCEPTED FOR REVIEW BY FDA

* AVENUE THERAPEUTICS INC - FDA SET A PRESCRIPTION DRUG USER FEE ACT (“PDUFA”) GOAL ACTION DATE OF OCTOBER 10, 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below